The trajectory of Sildenafil presents a complex case for investors in the medicinal sector. While initially a tremendous success, creating huge profits, the patent expiration and the subsequent flood of off-brand https://gambling793858.livebloggs.com/48549134/the-little-copyright-and-big-pharma-a-risky-investment